SC3 Research Group is a Neurology focused research enterprise conducting Phase 2-4 interventional clinical studies. We are an experienced team of researchers and board-certified neurologists conducting active studies in neurological indications including Multiple Sclerosis, Alzheimers disease, Parkinson's disease, Epilepsy, and post-Stroke.
